Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

75%

3 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
3(75.0%)
N/A
1(25.0%)
4Total
Phase 3(3)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT02200783Not ApplicableUnknown

Randomized Comparison of Radiological Exposure With TRIPTable® in Patients With Acute Coronary Syndromes

Role: lead

NCT01024257Phase 3Completed

Pterygium Treatment Using Single Beta-therapy as Adjuvant Treatment Compared to Conjunctival Autograft

Role: lead

NCT00876642Phase 3Completed

Trial Comparing Best Supportive Care to Aloe Vera Gel

Role: lead

NCT00858741Phase 3Completed

Palliative Radiotherapy for Bone Metastases: Single Versus Multiple Fractions.

Role: lead

All 4 trials loaded